J&J Accuses Amgen of Using Anticompetitive Sales Practices in Oncology Market

Drug Industry Daily
KEYWORDS courts
A A

Johnson & Johnson (J&J) filed an antitrust lawsuit in federal court this week accusing rival manufacturer Amgen of engaging in anticompetitive practices to monopolize the market for sales of anti-anemia drugs to oncology clinics.

To View This Article:

Login

Subscribe To Drug Industry Daily